Clinical Trials Insight: 700030110
Latest Information Update: 28 Apr 2024
Price :
$35 *
At a glance
- Drugs Nalotimagene-carmaleucel (Primary)
- Indications Haematological malignancies
- Focus Therapeutic Use
- Sponsors MolMed
- 25 Jan 2008 New trial record.